Search

Your search keyword '"Kulkarni, Anjana"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Kulkarni, Anjana" Remove constraint Author: "Kulkarni, Anjana"
32 results on '"Kulkarni, Anjana"'

Search Results

2. The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource

3. Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK)

5. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

7. The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource

9. Aberrant regulation of the DNA replication licensing system and Aurora kinases in epithelial ovarian carcinoma

11. Prenatal and pre‐implantation genetic testing for monogenic disorders for germline cancer susceptibility gene variants: UK joint consensus guidance.

14. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants inBRCA1andBRCA2

15. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2.

16. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2.

17. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

19. UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1and PALB2

20. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1and BRCA2

22. Structural Aberrations with Secondary Implications (SASIs): consensus recommendations for reporting of cancer susceptibility genes identified during analysis of Copy Number Variants (CNVs)

23. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

24. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

25. DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma

27. Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma

28. Prenatal diagnosis and pre‐implantation genetic diagnosis for cancer susceptibility conditions.

29. Multiple outcomes of the germline p16INK4a mutation affecting senescence and immunity in human skin.

30. The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2

31. Random Access Procedures in 5G IoT via NTN: System level performances

32. DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma.

Catalog

Books, media, physical & digital resources